Jesús Gil

Active 1998–2025

Also published as
Jesus Gil
96
Papers
30,176
Citations
74
h-index
94
i10-index

Citations

Citations per year for Jesús Gil1998: 1 citations1999: 5 citations2000: 18 citations2001: 23 citations2002: 38 citations2003: 30 citations2004: 35 citations2005: 43 citations2006: 104 citations2007: 148 citations2008: 145 citations2009: 195 citations2010: 277 citations2011: 296 citations2012: 327 citations2013: 332 citations2014: 336 citations2015: 324 citations2016: 368 citations2017: 333 citations2018: 351 citations2019: 870 citations2020: 1,349 citations2021: 1,537 citations2022: 1,482 citations2023: 1,252 citations2024: 1,990 citations2025: 1,198 citations2026: 34 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,476 citing papers, 24.6% of this breakdownChina: 2,213 citing papers, 15.7% of this breakdownUnited Kingdom: 1,126 citing papers, 8% of this breakdownGermany: 756 citing papers, 5.4% of this breakdownItaly: 564 citing papers, 4% of this breakdownJapan: 539 citing papers, 3.8% of this breakdownFrance: 516 citing papers, 3.6% of this breakdownSpain: 511 citing papers, 3.6% of this breakdownCanada: 410 citing papers, 2.9% of this breakdownNetherlands: 306 citing papers, 2.2% of this breakdownAustralia: 296 citing papers, 2.1% of this breakdownSouth Korea: 228 citing papers, 1.6% of this breakdown
0%24.6%Other 22.5%

Fields

  • Medicine45.4%
  • Biochemistry, Genetics and Molecular Biology40.6%
  • Immunology and Microbiology7.6%
  • Neuroscience2.9%
  • Agricultural and Biological Sciences0.9%
  • Engineering0.5%
  • Other2.1%

Topics

  • Telomeres, Telomerase, and Senescence8.3%
  • Epigenetics and DNA Methylation3.9%
  • Cancer-related molecular mechanisms research2.7%
  • RNA modifications and cancer2.6%
  • Immune cells in cancer2%
  • Genetics, Aging, and Longevity in Model Organisms1.9%
  • Other78.6%

Coauthors

All papers

Open in search
  1. Cellular Senescence: Defining a Path Forward

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 3,243

  2. Senescence and the SASP: many therapeutic avenues

    Authors: , - Genes & Development 2020 cited by 1,121

  3. A complex secretory program orchestrated by the inflammasome controls paracrine senescence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2013 cited by 2,225

  4. Mechanisms and functions of cellular senescence

    Authors: , - Journal of Clinical Investigation 2018 cited by 1,165

  5. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2011 cited by 1,597

  6. Senescence and aging: Causes, consequences, and therapeutic avenues

    Authors: , - The Journal of Cell Biology 2017 cited by 1,224

  7. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 cited by 234

  8. Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence

    Authors: , , , , , , , , , , , , , , , - Cell 2008 cited by 1,806

  9. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2015 cited by 771

  10. Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daohong Zhou, C. Norman Coleman - JNCI Journal of the National Cancer Institute 2021 cited by 338

  11. Guidelines for minimal information on cellular senescence experimentation in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johannes Grillari, Marco Demaria - Cell 2024 cited by 328

  12. Cardiac glycosides are broad-spectrum senolytics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Metabolism 2019 cited by 352

  13. Inhibition of IL-11 signalling extends mammalian healthspan and lifespan

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2024 cited by 209

  14. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2022 cited by 135

  15. Senescence in premalignant tumours

    Authors: , , , , , , , , , , , - Nature 2005 cited by 1,460

  16. Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Westaby, Juliet Carmichael, Maria D. Fenor de la Maza, Christina Yap, Ruth Matthews, Hannah Badham, Toby Prout, Alison Turner, Mona Parmar, Holly Tovey, Ruth Riisnaes, Penny Flohr, Jesús Gil, David Waugh, Shaun Decordova, Anna Schlag, Bianca Calì, Andrea Alimonti, Johann S. de Bono - Nature 2023 cited by 120

  17. AP-1 imprints a reversible transcriptional programme of senescent cells

    Authors: , , , , , , , , , , , - Nature Cell Biology 2020 cited by 252

  18. Galactose‐modified duocarmycin prodrugs as senolytics

    Authors: , , , , , , , - Aging Cell 2020 cited by 161

  19. PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 246

  20. Targeting senescence as an anticancer therapy

    Authors: , - Molecular Oncology 2022 cited by 99

  21. Similarities and interplay between senescent cells and macrophages

    Authors: , - The Journal of Cell Biology 2020 cited by 160

  22. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies

    Authors: , - Developmental Cell 2023 cited by 94

  23. Prostate carcinogenesis: inflammatory storms

    Authors: , , , , , , , , - Nature reviews. Cancer 2020 cited by 242

  24. Senescence as a therapeutically relevant response to CDK4/6 inhibitors

    Authors: , - Oncogene 2020 cited by 143